Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients

European Respiratory Journal

Volumn 36, Issue 6, 2010, Pages 1488-1490

  Aabye, M G ^a   Ruhwald, M ^a   PrayGod, G ^c   Jeremiah, K ^c   Faurholt Jepsen, M ^b   Faurholt Jepsen, D ^b   Range, N ^c   Friis, H ^b   Changalucha, J ^c   Andersen, A B ^a   Ravn, P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

BACTERIUM CULTURE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOCOMPROMISED PATIENT; INTERMETHOD COMPARISON; LETTER; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN INDUCTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SPUTUM ANALYSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOLOGICAL MARKERS; CHEMOKINE CXCL10; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOLOGIC TESTS; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TANZANIA; TUBERCULOSIS, PULMONARY;

EID: 78649721716     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00039010     Document Type: Letter

References (9)

1. World Health Organisation. Global tuberculosis control: epidemiology, strategy, financing. Geneva, WHO, 2009.
2. Domínguez J, Latorre I, Altet N, et al. IFN-γ-release assays to diagnose TB infection in the immunocompromised individual. Expert Rev Resp Med 2009; 3: 309-327.
3. Aabye MG, Ravn P, PrayGod G, et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS ONE 2009; 4: e4220.
4. Kabeer BS, Sikhamani R, Raja A. Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 2010; 24: 323-325.
5. Ruhwald M, Bodmer T, Maier C, et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008; 32: 1607-1615.
6. Ruhwald M, Petersen J, Kofoed K, et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE 2008; 3: e2858.
7. Korpi-Steiner NL, Bates ME, Lee WM, et al. Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. J Leukoc Biol 2006; 80: 1364-1374.
8. Lighter J, Rigaud M, Huie M, et al. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int J Tuberc Lung Dis 2009; 13: 731-736.
9. Syed Ahamed KB, Raman B, Thomas A, et al. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS ONE 2010; 5: e9051.